Close

BG Medicine (BGMD) Announces 1-for-4 Reverse Stock Spit

July 8, 2015 5:02 PM EDT Send to a Friend
BG Medicine, Inc. (Nasdaq: BGMD), the developer of the BGM Galectin-3® Test, today announced the effectiveness of a one-for-four reverse ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login